FR2358399A1 - 5-m-tolyloxy-uracile, agent anti-ulceres - Google Patents

5-m-tolyloxy-uracile, agent anti-ulceres

Info

Publication number
FR2358399A1
FR2358399A1 FR7721285A FR7721285A FR2358399A1 FR 2358399 A1 FR2358399 A1 FR 2358399A1 FR 7721285 A FR7721285 A FR 7721285A FR 7721285 A FR7721285 A FR 7721285A FR 2358399 A1 FR2358399 A1 FR 2358399A1
Authority
FR
France
Prior art keywords
tolyloxy
uracil
ulceres
agent
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7721285A
Other languages
English (en)
French (fr)
Other versions
FR2358399B1 (https=
Inventor
Christopher Andrew Lipinski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of FR2358399A1 publication Critical patent/FR2358399A1/fr
Application granted granted Critical
Publication of FR2358399B1 publication Critical patent/FR2358399B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7721285A 1976-07-16 1977-07-11 5-m-tolyloxy-uracile, agent anti-ulceres Granted FR2358399A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/706,123 US4080454A (en) 1976-07-16 1976-07-16 5-M-Tolyloxyuracil, anti-ulcer agent

Publications (2)

Publication Number Publication Date
FR2358399A1 true FR2358399A1 (fr) 1978-02-10
FR2358399B1 FR2358399B1 (https=) 1980-10-17

Family

ID=24836300

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7721285A Granted FR2358399A1 (fr) 1976-07-16 1977-07-11 5-m-tolyloxy-uracile, agent anti-ulceres

Country Status (29)

Country Link
US (1) US4080454A (https=)
JP (1) JPS5337673A (https=)
AR (1) AR213652A1 (https=)
AT (1) AT351561B (https=)
BE (1) BE856710A (https=)
CA (1) CA1061788A (https=)
CH (1) CH622512A5 (https=)
CS (1) CS212264B2 (https=)
DD (1) DD131556A5 (https=)
DE (1) DE2731736A1 (https=)
DK (1) DK139029B (https=)
EG (1) EG12762A (https=)
ES (1) ES460686A1 (https=)
FI (1) FI772183A7 (https=)
FR (1) FR2358399A1 (https=)
GB (1) GB1542178A (https=)
GR (1) GR68686B (https=)
HU (1) HU177713B (https=)
IL (1) IL52409A (https=)
LU (1) LU77764A1 (https=)
NL (1) NL7707729A (https=)
NO (1) NO772489L (https=)
PH (1) PH13190A (https=)
PL (1) PL103783B1 (https=)
PT (1) PT66808B (https=)
SE (1) SE421125B (https=)
SU (1) SU673169A3 (https=)
YU (1) YU171677A (https=)
ZA (1) ZA773927B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55158095A (en) * 1979-05-25 1980-12-09 Zenkosha Tokei Kk Controller for washing machine
JP5113752B2 (ja) 2005-08-22 2013-01-09 メリオール・ファーマスーティカルズ・ワン・インコーポレイテッド Lynキナーゼの活性を調節し、関連する疾患を治療するための方法および製剤
CA2678813A1 (en) * 2007-02-20 2008-08-28 Melior Pharmaceuticals I, Inc. Methods of identifying activators of lyn kinase
CA2693809A1 (en) * 2007-07-23 2009-01-29 Melior Discovery, Inc. Methods of activating irs-1 and akt
US8552184B2 (en) * 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
US20130158055A1 (en) 2010-05-28 2013-06-20 Andrew G. Reaume Prevention Of Pancreatic Beta Cell Degeneration
SG11201909406VA (en) 2017-04-10 2019-11-28 Melior Pharmaceuticals I Inc Treatment of adipocytes
US20210106581A1 (en) 2018-02-21 2021-04-15 Melior Pharmaceuticals I, Inc. Treatment Of Liver Diseases

Also Published As

Publication number Publication date
SU673169A3 (ru) 1979-07-05
IL52409A0 (en) 1977-08-31
DE2731736A1 (de) 1978-01-26
HU177713B (en) 1981-12-28
FR2358399B1 (https=) 1980-10-17
PL199633A1 (pl) 1978-04-10
PT66808A (en) 1977-08-01
CH622512A5 (https=) 1981-04-15
FI772183A7 (https=) 1978-01-17
SE421125B (sv) 1981-11-30
AU2663877A (en) 1978-05-18
DK318177A (https=) 1978-01-17
SE7707471L (sv) 1978-01-17
ES460686A1 (es) 1978-12-01
PT66808B (en) 1978-12-21
AT351561B (de) 1979-08-10
NO772489L (no) 1978-01-17
US4080454A (en) 1978-03-21
NL7707729A (nl) 1978-01-18
DD131556A5 (de) 1978-07-05
AR213652A1 (es) 1979-02-28
JPS5512017B2 (https=) 1980-03-29
EG12762A (en) 1979-12-31
PH13190A (en) 1980-01-16
IL52409A (en) 1979-11-30
DK139029B (da) 1978-12-04
YU171677A (en) 1982-06-30
BE856710A (fr) 1978-01-11
CA1061788A (en) 1979-09-04
CS212264B2 (en) 1982-03-26
ATA509277A (de) 1979-01-15
ZA773927B (en) 1978-05-30
GB1542178A (en) 1979-03-14
JPS5337673A (en) 1978-04-06
PL103783B1 (pl) 1979-07-31
GR68686B (https=) 1982-02-01
LU77764A1 (https=) 1978-02-02
DK139029C (https=) 1979-05-07

Similar Documents

Publication Publication Date Title
FR2358157A1 (fr) Oligosaccharides sulfates utiles notamment comme inhibiteurs du complement
JPS53112299A (en) Production of alumina sol
FR2358399A1 (fr) 5-m-tolyloxy-uracile, agent anti-ulceres
SU423285A3 (https=)
TR20150A (tr) Tiyazoli'sinamik asit nitrilleri bunlarin imalati ve pestitler o'arak kullanilmalari
FR1509084A (fr) Procédé de récupération de sélénium iv utilisé comme catalyseur d'oxydation en solution
GB1187480A (en) Cleaning of Apparatus Used in the Manufacture of Polyethylene Terephthalate
BE777905A (fr) Procede d'oxydation electrochimique
BE833390A (fr) Procede de traitement thermique de boues, en boues particulier de boues d'hydrate de magnesie
SU510168A3 (ru) Способ количественного опреде-лени веществ,способных к фермен-тативному окислению в водномрастворе
FR2287911A1 (fr) Sulfates de pullulane, leurs sels et leur procede de preparation
ES450299A1 (es) Un procedimiento de fabricacion de nuevos compuestos quimi- cos derivados de n-pinolidin-2-etilamina.
SE423707B (sv) Forfarande for behandling av kiselaluminiumhaltiga material innehallande ti och fe samt mindre en 0,1 % k?7120 i syfte att erhalla metallurgiskt ren aluminiumoxid
KR830006172A (ko) 2,6-디클로로-4-니트로아닐린의 제조방법
GB1241839A (en) Pyridinium compounds
GB1254085A (en) Anthranilic acid derivatives and their use in anaesthetising fish
GB1395929A (en) Thioureas
SU482448A1 (ru) Способ получени гем-дихлор-1,2диарилазиридинов
SU464892A1 (ru) Спосооб управлени процессом обработки отходов солевых производств"
FR2306168A1 (fr) Procede de production de solutions basiques d'aluminium et application de ces solutions en traitement des eaux
SU506619A1 (ru) Способ выделени и очистки фибринолитического препарата
SU704621A1 (ru) Способ лечени нарушений функционального состо ни печени при синдроме массивных трансфузий крови
Chuvilova Corrosion of Ti VT 1-0 and Some Steels in Hydrolyzed H 2 SO 4 Production of TiO 2
JPS5547119A (en) Treatment of exhaust gas containing fluorine
FR1929M (fr) Compositions contenant du diphosphopyridine nucléotide ou du diphosphopyridine nucléotide réduit, utiles dans le traitement de l'alcoolisme.

Legal Events

Date Code Title Description
ST Notification of lapse